Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Adamchak currently holds 253 shares of Bionano Genomics, Inc. (BNGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Adamchak has been a net neutral trader of BNGO stock. They have purchased $0 and sold $0 worth of shares.
Mark Adamchak's most recent insider trade was on Jun 3, 2026, when they sold 7 shares at $1.30 per share.
Mark Adamchak serves as Executive at Bionano Genomics, Inc. (BNGO). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Mark Adamchak holds the position of Executive at Bionano Genomics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Mark Adamchak has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Mark Adamchak was on Jun 3, 2026, when they sold $9 worth of BNGO shares. This transaction involved 7 shares at $1.30 per share.
Mark Adamchak currently owns 253 shares of Bionano Genomics, Inc. (BNGO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Adamchak's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Adamchak has 2 Form 4 filings on record as an insider at Bionano Genomics, Inc..
Set alerts for Mark Adamchak and 40,000+ other insiders.